Six-month outcomes of infliximab and tocilizumab therapy in non-infectious retinal vasculitis.

Irmak KaracaGunay UludagWataru MatsumiyaJonathan RegenoldChristopher OrAzadeh MobasserianMuhammad Sohail HalimMoosa H ZaidiSherin LajevardiAmi DongchauHashem H Ghoraba Quan Dong Nguyen

Published in: Eye (London, England) (2022)

IFX and TCZ infusions showed statistically significant improvement of non-infectious RV as shown by ASUWOG FA Scoring System. TCZ, as well as IFX, appeared to be effective treatment options for non-infectious RV.

Keyphrases

mycobacterium tuberculosis
rheumatoid arthritis
optical coherence tomography
diabetic retinopathy
stem cells
ulcerative colitis
rheumatoid arthritis patients
systemic lupus erythematosus
mesenchymal stem cells
bone marrow
weight loss
replacement therapy